Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSumracki, N.-
dc.contributor.authorHutchinson, M.-
dc.contributor.authorGentgall, M.-
dc.contributor.authorBriggs, N.-
dc.contributor.authorWilliams, D.-
dc.contributor.authorRolan, P.-
dc.identifier.citationPLoS One, 2012; 7(6):1-8-
dc.description.abstractBACKGROUND: Patients with unilateral sciatica have heightened responses to intradermal capsaicin compared to pain-free volunteers. No studies have investigated whether this pain model can screen for novel anti-neuropathic agents in patients with pre-existing neuropathic pain syndromes. AIM: This study compared the effects of pregabalin (300 mg) and the tetracycline antibiotic and glial attenuator minocycline (400 mg) on capsaicin-induced spontaneous pain, flare, allodynia and hyperalgesia in patients with unilateral sciatica on both their affected and unaffected leg. METHODS/RESULTS: Eighteen patients with unilateral sciatica completed this randomised, double-blind, placebo-controlled, three-way cross-over study. Participants received a 10 mg dose of capsaicin into the middle section of their calf on both their affected and unaffected leg, separated by an interval of 75 min. Capsaicin-induced spontaneous pain, flare, allodynia and hyperalgesia were recorded pre-injection and at 5, 20, 40, 60 and 90 min post-injection. Minocycline tended to reduce precapsaicin injection values of hyperalgesia in the affected leg by 28% (95% CI 0% to 56%). The area under the effect time curves for capsaicin-induced spontaneous pain, flare, allodynia and hyperalgesia were not affected by either treatment compared to placebo. Significant limb differences were observed for flare (AUC) (-38% in affected leg, 95% CI for difference -19% to -52%). Both hand dominance and sex were significant covariates of response to capsaicin. CONCLUSIONS: It cannot be concluded that minocycline is unsuitable for further evaluation as an anti-neuropathic pain drug as pregabalin, our positive control, failed to reduce capsaicin-induced neuropathic pain. However, the anti-hyperalgesic effect of minocycline observed pre-capsaicin injection is promising pilot information to support ongoing research into glialmediated treatments for neuropathic pain. The differences in flare response between limbs may represent a useful biomarker to further investigate neuropathic pain. Inclusion of a positive control is imperative for the assessment of novel therapies for neuropathic pain.-
dc.description.statementofresponsibilityNicole M. Sumracki, Mark R. Hutchinson, Melanie Gentgall, Nancy Briggs, Desmond B. Williams and Paul Rolan-
dc.publisherPublic Library of Science-
dc.rightsCopyright: © 2012 Sumracki et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.-
dc.subjectgamma-Aminobutyric Acid-
dc.subjectTreatment Outcome-
dc.subjectDrug Therapy, Combination-
dc.subjectInjections, Intradermal-
dc.subjectAnalysis of Variance-
dc.subjectCross-Over Studies-
dc.subjectDouble-Blind Method-
dc.subjectTime Factors-
dc.subjectMiddle Aged-
dc.titleThe effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica-
dc.typeJournal article-
dc.identifier.orcidHutchinson, M. [0000-0003-2154-5950]-
Appears in Collections:Aurora harvest
Pharmacology publications

Files in This Item:
File Description SizeFormat 
hdl_72969.pdfPublished version1.11 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.